Skip to main content

Table 4 Cox regression analyses for overall survival in patients with LUSC from TCGA

From: Construction and validation of a novel prognostic model for lung squamous cell cancer based on N6-methyladenosine-related genes

 

Univariate Cox

Multivariate Cox

HR(95%CI)

p-value

HR(95%CI)

p-value

Risk score

1.90(1.10~3.28)

0.020*

2.44(1.21~3.56)

0.029*

Sex

0.53(0.28~1.04)

0.050*

0.18(0.06~1.22)

0.000*

Cancer status

3.72(1.93~7.16)

0.000*

3.20(1.65~6.21)

0.000*

T stage

1.37(0.98~1.94)

0.079

1.95(1.30~2.45)

0.017*

Age

1.05(0.59~1.87)

0.878

  

Race

0.37(0.09~1.56)

0.116

  

Smoking history

0.97(0.13~7.03)

0.974

  

Pathologic stage

1.25(0.93~1.67)

0.156

  

N stage

1.24(0.88~1.73)

0.236

  

M stage

0.60(0.11~3.09)

0.475

  
  1. CI confidence interval, HR hazard ratio, LUSC lung squamous cell cancer, TCGA The Cancer Genome Atlas
  2. *p < 0.05